# Safety and Performance of Agilik in CP

> **NCT05746871** · NA · TERMINATED · sponsor: **IRCCS Eugenio Medea** · enrollment: 9 (actual)

## Conditions studied

- Cerebral Palsy

## Interventions

- **DEVICE:** Agilik
- **OTHER:** standard care

## Key facts

- **NCT ID:** NCT05746871
- **Lead sponsor:** IRCCS Eugenio Medea
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-03-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The study was discontinued after the expiration of Ethics Committee approval, as the required conditions to continue the trial were no longer available.
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05746871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05746871, "Safety and Performance of Agilik in CP". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05746871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*